Decoy Therapeutics, Inc. (DCOY)
2.67
-0.06
(-2.20%)
USD |
NASDAQ |
Sep 11, 16:00
2.63
-0.04
(-1.50%)
After-Hours: 20:00
Decoy Therapeutics Price to Book Value : 0.3287 for Sept. 11, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 0.3287 |
| September 10, 2026 | 0.3361 |
| September 09, 2026 | 0.3398 |
| September 08, 2026 | 0.3238 |
| September 04, 2026 | 0.3312 |
| September 03, 2026 | 0.3546 |
| September 02, 2026 | 0.3669 |
| September 01, 2026 | 0.3768 |
| August 31, 2026 | 0.3755 |
| August 28, 2026 | 0.3571 |
| August 27, 2026 | 0.3657 |
| August 26, 2026 | 0.3706 |
| August 25, 2026 | 0.3669 |
| August 24, 2026 | 0.3829 |
| August 21, 2026 | 0.394 |
| August 20, 2026 | 0.4038 |
| August 19, 2026 | 0.4198 |
| August 18, 2026 | 0.4519 |
| August 17, 2026 | 0.4334 |
| August 14, 2026 | 0.4408 |
| August 13, 2026 | 0.4346 |
| August 12, 2026 | 0.4432 |
| August 11, 2026 | 0.4765 |
| August 10, 2026 | 0.4716 |
| August 07, 2026 | 0.4839 |
| Date | Value |
|---|---|
| August 06, 2026 | 0.4999 |
| August 05, 2026 | 0.5159 |
| August 04, 2026 | 0.538 |
| August 03, 2026 | 0.5344 |
| July 31, 2026 | 0.506 |
| July 30, 2026 | 0.4826 |
| July 29, 2026 | 0.4962 |
| July 28, 2026 | 0.4974 |
| July 27, 2026 | 0.4605 |
| July 24, 2026 | 0.6205 |
| July 23, 2026 | 0.6082 |
| July 22, 2026 | 0.6095 |
| July 21, 2026 | 0.6058 |
| July 20, 2026 | 0.6532 |
| July 17, 2026 | 0.6907 |
| July 16, 2026 | 0.7375 |
| July 15, 2026 | 0.7609 |
| July 14, 2026 | 0.708 |
| July 13, 2026 | 0.719 |
| July 10, 2026 | 0.7277 |
| July 09, 2026 | 0.7714 |
| July 08, 2026 | 0.708 |
| July 07, 2026 | 0.8643 |
| July 06, 2026 | 0.8926 |
| July 02, 2026 | 0.90 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Palatin Technologies, Inc. | 1.979 |
| Unicycive Therapeutics, Inc. | 2.766 |
| Nuvectis Pharma, Inc. | 70.51 |
| ACADIA Pharmaceuticals, Inc. | 3.666 |
| Alnylam Pharmaceuticals, Inc. | 24.56 |
Price to Book Value Related Metrics
| PS Ratio | 4.798 |
| Price | 2.67 |
| Earnings Yield | -1.77K% |
| Market Cap | 1.420M |